b) Warrant that this Company’s securities will be listed or will continue to be listed on the
Exchange; or

c) Take any responsibility for the financial or other soundness of this Company, its promoters, its
management or any scheme or project of this Company;

and it should not for any reason be deemed or construed that this offer document has been cleared or approved
by the Exchange. Every person who desires to apply for or otherwise acquires any securities of this Company
may do so pursuant to independent inquiry, investigation and analysis and shall not have any claim against the
Exchange whatsoever by reason of any loss which may be suffered by such person consequent to or in
connection with such subscription/acquisition whether by reason of anything stated or omitted to be stated
herein or for any other reason whatsoever.

Disclaimer Clause of the NSE

As required, a copy of this Offer Document has been submitted to National Stock Exchange of India Limited
(hereinafter referred to as NSE). NSE has given vide its letter Ref.: NSE/LIST/1203 dated September 08, 2021
permission to the Issuer to use the Exchange’s name in this Offer Document as one of the Stock Exchanges on
which this Issuer’s securities are proposed to be listed. The Exchange has scrutinized this draft offer document
for its limited internal purpose of deciding on the matter of granting the aforesaid permission to this Issuer. It is
to be distinctly understood that the aforesaid permission given by NSE should not in any way be deemed or
construed that the offer document has been cleared or approved by NSE; nor does it in any manner warrant,
certify or endorse the correctness or completeness of any of the contents of this offer document; nor does it
warrant that this Issuer’s securities will be listed or will continue to be listed on the Exchange; nor does it take
any responsibility for the financial or other soundness of this Issuer, its promoters, its management or any
scheme or project of this Issuer.

Every person who desires to apply for or otherwise acquire any securities of this Issuer may do so pursuant to
independent inquiry, investigation and analysis and shall not have any claim against the Exchange whatsoever
by reason of any loss which may be suffered by such person consequent to or in connection with such
subscription /acquisition whether by reason of anything stated or omitted to be stated herein or any other reason
whatsoever.

Listing

Applications will be made to the Stock Exchanges for permission to deal in and for an official quotation of the
Equity Shares being issued and sold in the Offer. BSE will be the Designated Stock Exchange with which the
Basis of Allotment will be finalized.

Consents

Consents in writing of: (a) the Selling Shareholders, our Directors, our Company Secretary and Compliance
Officer, the Auditors of our Company, the Legal Advisors to our Company as to Indian Law, the Legal Advisors
to the BRLMs as to Indian Law, the Legal Counsel to the BRLMs as to International Law, the Bankers to our
Company and (b) the BRLMs, the Registrar to the Offer, the Syndicate Members, the Escrow Collection Bank,
the Refund Bank, the Public Offer Account Bank, the Sponsor Bank and Ken Research to act in their respective
capacities, have been obtained and filed along with a copy of the Red Herring Prospectus with the RoC as
required under the Companies Act, 2013 and such consents that have been obtained have not been withdrawn up
to the time of delivery of this Prospectus for filing with the RoC.

Experts
Our Company has not obtained any expert opinions other than as disclosed below.

Our Company has received written consent dated January 6, 2022 from our Statutory Auditors, namely, B S R &
Co. LLP, Chartered Accountants, to include their name in this Prospectus as required under Section 26(5) of the
Companies Act read with SEBI ICDR Regulations and as an “expert” as defined under Section 2(38) of the
Companies Act to the extent and in their capacity as a statutory auditor of our Company and in respect of the
examination report of the Statutory Auditors on the Restated Consolidated Financial Information dated January
6, 2022 and the statement of possible special tax benefits dated August 18, 2021, included in this Prospectus and

393
